Australia approves Pfizer’s coronavirus vaccine for use, AUD/USD on the bids

Dhwani Mehta FXStreet

The Therapeutic Goods Administration (TGA), Australia’s medical regulator, gave a green light to Pfizer/ BioNTech COVID-19 vaccine for use in the country on Monday.

Pfizer’s vaccine met safety, efficacy and quality standards and has been approved for people aged 16 and older, the TGA said.

Responding to the vaccine authorization, Prime Minister Scott Morrison said, ‘Today's approval is another big step forward for our community, particularly in the protection of our most vulnerable people.”

Australia’s Health Minister Greg Hunt said that the TGA had "placed safety above all else" during the approval process.

"This approval and the upcoming rollout of the vaccine will play an important part in our ability to manage the pandemic in 2021," he added.

AUD/USD draws bids as US stock futures rally

Author

Dhwani Mehta

FXStreet

Residing in Mumbai (India), Dhwani is a Senior Analyst and Manager of the Asian session at FXStreet. She has over 10 years of experience in analyzing and covering the global financial markets, with specialization in Forex and commodities markets.

EUR/USD trims gains, back below 1.1800

EUR/USD now loses some upside momentum, returning to the area below the 1.1800 support as the Greenback manages to regain some composure following the SCOTUS-led pullback earlier in the session.

GBP/USD off highs, recedes to the sub-1.3500 area

Following earlier highs north of 1.3500 the figure, GBP/USD now faces some renewed downside pressure, revisiting the 1.3490 zone as the US Dollar manages to regain some upside impulse in the latter part of the NA session on Friday.

Gold climbs to weekly tops, approaches $5,100/oz

Gold keeps the bid tone well in place at the end of the week, now hitting fresh weekly highs and retargeting the key $5,100 mark per troy ounce. The move higher in the yellow metal comes in response to ongoing geopolitical tensions in the Middle East and modest losses in the US Dollar.